CelLBxHealth Statistics

Total Valuation

CelLBxHealth has a market cap or net worth of EUR 4.21 million. The enterprise value is 2.38 million.

Market Cap	4.21M
Enterprise Value	2.38M

Important Dates

The next estimated earnings date is Wednesday, December 10, 2025.

Earnings Date	Dec 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	321.53M
Shares Outstanding	n/a
Shares Change (YoY)	+22.34%
Shares Change (QoQ)	-0.09%
Owned by Insiders (%)	10.90%
Owned by Institutions (%)	58.90%
Float	237.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.37
PB Ratio	0.31
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.13
EV / Sales	0.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.18

Financial Position

The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.31.

Current Ratio	3.13
Quick Ratio	2.63
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-0.32
Interest Coverage	-51.36

Financial Efficiency

Return on equity (ROE) is -87.18% and return on invested capital (ROIC) is -46.31%.

Return on Equity (ROE)	-87.18%
Return on Assets (ROA)	-39.98%
Return on Invested Capital (ROIC)	-46.31%
Return on Capital Employed (ROCE)	-109.37%
Revenue Per Employee	25,724
Profits Per Employee	-154,697
Employee Count	119
Asset Turnover	0.10
Inventory Turnover	1.08

Taxes

Income Tax	-845,784
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-88.70%
50-Day Moving Average	0.02
200-Day Moving Average	0.07
Relative Strength Index (RSI)	44.13
Average Volume (20 Days)	324

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CelLBxHealth had revenue of EUR 3.06 million and -18.41 million in losses. Loss per share was -0.06.

Revenue	3.06M
Gross Profit	960,110
Operating Income	-19.06M
Pretax Income	-19.25M
Net Income	-18.41M
EBITDA	-18.14M
EBIT	-19.06M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 6.15 million in cash and 4.28 million in debt, giving a net cash position of 1.87 million.

Cash & Cash Equivalents	6.15M
Total Debt	4.28M
Net Cash	1.87M
Net Cash Per Share	n/a
Equity (Book Value)	13.64M
Book Value Per Share	0.04
Working Capital	7.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.13 million and capital expenditures -430,475, giving a free cash flow of -13.56 million.

Operating Cash Flow	-13.13M
Capital Expenditures	-430,475
Free Cash Flow	-13.56M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	31.36%
Operating Margin	-622.48%
Pretax Margin	-629.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CelLBxHealth does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.34%
Shareholder Yield	-22.34%
Earnings Yield	-437.67%
FCF Yield	-322.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CelLBxHealth has an Altman Z-Score of -10.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.16
Piotroski F-Score	2